Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation (PRCT)
NasdaqGM: PRCT
· 即時價格 · USD
21.85
+0.94 (4.50%)
收盤價： Sep 02, 2026, 4:25 PM
股價、關鍵數字和最新消息，都在這一頁。
PROCEPT BioRobotics Corporation（PRCT）股價、分析與資料
無可用資料
| 買價 | 13.9 |
| 市值 | 1.24B |
| 營收 (ttm) | 337M |
| 淨利（ttm） | -110M |
| 0.89 | |
| -1.95 | |
| n/a | |
| -18.95 | |
| P/B (ttm) | 3.68 |
| P/S (ttm) | 3.71 |
| 財報日期 | Nov 4, 2026 |
| 賣價 | 22.04 |
| 成交量 | 345,314 |
| 20 日平均成交量 | 1,578,080 |
| 開盤價 | 20.86 |
| 前收盤價 | 20.91 |
| 當日區間 | 20.80 - 22.00 |
| 52 週範圍 | 16.66 - 41.51 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided rob...
完整的公司簡介財報驚奇
PROCEPT BioRobotics 已於 Aug 4, 2026 公布季度財報：
- 營收為 $94.5M 低於預期 $0, 年增 19.34% 成長.
- 每股盈餘為 -0.47 低於預期 -0.02, 年增 -34.29% 下滑.
第 1 頁，共 2 頁